- ICH GCP
- US Clinical Trials Registry
- Forskere
- Norge
- Multippelt myelom
Medisinske spesialister fra Norge merket som etterforskere i kliniske studier som studerer Multippelt myelom
Totalt 6 resultater
-
Einar Haukås, MD, PhDSett i:
- Stavanger, Helse Stavanger HF
Prøver:- NCT04939844 (Hovedetterforsker)
Betingelser: -
Fredrik SchjesvoldSett i:
- Oslo, GSK Investigational Site
- Oslo, Oslo Universitetssykehus-Ulleval Hospital
- Oslo, Oslo University Hospital
Prøver:- NCT03215030 (Hovedetterforsker)
- NCT04126200 (Hovedetterforsker)
- NCT04939844 (Hovedetterforsker)
Betingelser: -
Frida B. Askeland, MDSett i:
- Oslo, Oslo University Hospital
Prøver:- NCT04939844 (Underetterforsker)
Betingelser: -
Mona-Elisabeth Revheim, MDSett i:
- Oslo, Oslo University Hosptal
Prøver:- NCT03966443 (Hovedetterforsker)
Betingelser: -
Tobias S. Slørdahl, MD, PhDSett i:
- Trondheim, St. Olav University Hospital
Prøver:- NCT04939844 (Hovedetterforsker)
Betingelser:
Kliniske studier på Multippelt myelom
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)AvsluttetMyelom, multippel | Myelom-multippelForente stater
-
Tel-Aviv Sourasky Medical CenterFullførtPlasmacellemyelom | Myelom-multippel | Myelom multippel | Myelom, plasmacelleIsrael
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthAvsluttetMyelom-multippel | Myelom, plasmacelle | MyelomatoseForente stater
-
University of ChicagoNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationAvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TilbaketrukketStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom